Aurora Cannabis (TSE:ACB) Trading Up 12.7%

Shares of Aurora Cannabis Inc. (TSE:ACB) shot up 12.7% during trading on Tuesday . The stock traded as high as C$6.33 and last traded at C$6.31. 861,969 shares changed hands during trading, an increase of 63% from the average session volume of 527,252 shares. The stock had previously closed at C$5.60.

Analyst Ratings Changes

Several research firms have recently commented on ACB. Jefferies Financial Group reduced their price target on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. CIBC reduced their price target on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. Finally, Canaccord Genuity Group raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price target on the stock in a research report on Friday, February 9th.

Aurora Cannabis Trading Up 13.0 %

The company has a market cap of C$351.24 million, a PE ratio of -0.08 and a beta of 2.83. The company has a quick ratio of 2.48, a current ratio of 3.79 and a debt-to-equity ratio of 18.51. The business has a 50-day simple moving average of C$2.75 and a 200-day simple moving average of C$1.43.

Aurora Cannabis (TSE:ACB) last announced its earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C($0.10) by C($0.10). The firm had revenue of C$72.61 million during the quarter, compared to analysts’ expectations of C$63.50 million. Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. On average, analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.